These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15841160)

  • 1. [A new strategy to treat hyperhomocysteinemia].
    Geng B; Chang L; Du JB; Tang CS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):215-9. PubMed ID: 15841160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats.
    Chang L; Xu J; Yu F; Zhao J; Tang X; Tang C
    Amino Acids; 2004 Aug; 27(1):37-48. PubMed ID: 15309570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats.
    Chang L; Geng B; Yu F; Zhao J; Jiang H; Du J; Tang C
    Amino Acids; 2008 May; 34(4):573-85. PubMed ID: 18071843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia abrogates fasting-induced cardioprotection against ischemia/reperfusion by limiting bioavailability of hydrogen sulfide anions.
    Nakano S; Ishii I; Shinmura K; Tamaki K; Hishiki T; Akahoshi N; Ida T; Nakanishi T; Kamata S; Kumagai Y; Akaike T; Fukuda K; Sano M; Suematsu M
    J Mol Med (Berl); 2015 Aug; 93(8):879-89. PubMed ID: 25740079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine.
    Yalçinkaya S; Unlüçerçi Y; Giriş M; Olgaç V; Doğru-Abbasoğlu S; Uysal M
    Nutrition; 2009 Apr; 25(4):436-44. PubMed ID: 19056240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur-Containing Amino Acids and Lipid Metabolism.
    Blachier F; Andriamihaja M; Blais A
    J Nutr; 2020 Oct; 150(Suppl 1):2524S-2531S. PubMed ID: 33000164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation.
    Villa P; Suriano R; Costantini B; Macrì F; Ricciardi L; Campagna G; Lanzone A
    Clin Chem Lab Med; 2007; 45(2):130-5. PubMed ID: 17311496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consequences of moderate hyperhomocysteinemia in internal medicine].
    Zák A; Zeman M
    Cas Lek Cesk; 2004; 143(6):367-74. PubMed ID: 15309862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid.
    Kolling J; Scherer EB; da Cunha AA; da Cunha MJ; Wyse AT
    Cardiovasc Toxicol; 2011 Mar; 11(1):67-73. PubMed ID: 21076891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methionine-homocysteine cycle and its effects on cognitive diseases.
    Miller AL
    Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine to hydrogen sulfide or hypertension.
    Sen U; Mishra PK; Tyagi N; Tyagi SC
    Cell Biochem Biophys; 2010 Jul; 57(2-3):49-58. PubMed ID: 20387006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homocysteine and cardiovascular risk].
    Lutteri L; Chapelle JP; Gielen J
    Rev Med Liege; 1999 Jun; 54(6):541-7. PubMed ID: 10446525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
    Zulli A; Lau E; Wijaya BP; Jin X; Sutarga K; Schwartz GD; Learmont J; Wookey PJ; Zinellu A; Carru C; Hare DL
    Hypertension; 2009 Jun; 53(6):1017-22. PubMed ID: 19398656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.